Skip to main content
Watch Insiders
ANTXHealthcare

AN2 Therapeutics Inc (ANTX) Insider Trading

In the last 90 days, 3 AN2 Therapeutics Inc (ANTX) insiders reported 1 open-market purchase totaling $11,602 and 4 sales totaling $318,205. The most recent open-market purchase was reported on Sep 1, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$11,602
Corporate buyers
1
Latest transaction
Sep 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 9, 2026Robin Shane ReadnourDirectorSale1,108$6.02$6,675
Sep 8, 2026Robin Shane ReadnourDirectorSale16,119$6.04$97,323
Sep 1, 2026Sarah Joanne WilliamsPrincipal Accounting OfficerSale272$5.53$1,504
Sep 1, 2026Margaret M FitzPatrickDirectorOpen Market Purchase2,098$5.53$11,602
Aug 17, 2026Robin Shane ReadnourDirectorSale35,402$6.01$212,702
Jul 8, 2026Joshua M EizenSee RemarksSale5,945$4.17$24,803
May 29, 2026Sarah Joanne WilliamsPrincipal Accounting OfficerSale265$4.43$1,174

Common questions

ANTX insider trading FAQ

Are ANTX insiders buying or selling?
Over the last 90 days, ANTX insiders were net sellers, reporting $11,602 of open-market purchases and $318,205 of sales.
When was the last ANTX insider purchase?
The most recent open-market purchase of AN2 Therapeutics Inc stock by an insider was reported on Sep 1, 2026, one of 1 purchase in the last 90 days.
Where does ANTX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that AN2 Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.